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Background: Solely in Europoe, Salmonella Typhimurium causes more than 100,000 infections per year. Improved
detection of livestock colonised with S. Typhimurium is necessary to prevent foodborne diseases. Currently,
commercially available ELISA assays are based on a mixture of O-antigens (LPS) or total cell lysate of Salmonella and
are hampered by cross-reaction. The identification of novel immunogenic proteins would be useful to develop
ELISA based diagnostic assays with a higher specificity.
Results: A phage display library of the entire Salmonella Typhimurium genome was constructed and 47
immunogenic oligopeptides were identified using a pool of convalescent sera from pigs infected with Salmonella
Typhimurium. The corresponding complete genes of seven of the identified oligopeptids were cloned. Five of them
were produced in E. coli. The immunogenic character of these antigens was validated with sera from pigs infeced
with S. Tyhimurium and control sera from non-infected animals. Finally, human antibody fragments (scFv) against
these five antigens were selected using antibody phage display and characterised.
Conclusion: In this work, we identified novel immunogenic proteins of Salmonella Typhimurium and generated
antibody fragments against these antigens completely based on phage display. Five immunogenic proteins were
validated using a panel of positive and negative sera for prospective applications in diagnostics of Salmonela
Typhimurium.Background
Salmonella spec. is a genus of the Enterobacteriaceae. Two
species are in the genus Salmonella: S. bongeri and S.
enterica [1]. Salmonella enterica is classified in serogroups
and serovars on the basis of their O- and H-antigens
(somatic and flagellar antigens) [2,3]. So far, 2800 Salmon-
ella enterica gene families and more than 2500 serovars
are known. More than 1500 serovars belong to the sub-
species Salmonella enterica subspecies enterica [4]. These
pathogens cause foodborne gastrointestinal infections,
usually through raw poultry and pork, but it can also be
found in non-alcoholic beer or seafood. The subspecies
enterica is the cause of 99% of human Salmonella* Correspondence: m.hust@tu-bs.de
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reproduction in any medium, provided the orinfections. The prevailent serovars are Typhimurium and
Enteritidis [4-7]. The most reported phage types for Sal-
monella Typhimurium are DT193, U302 and DT104.
Infections with the latter two phage types increased in
2009 [5]. Human infections with phage type DT104 are
particularly critical, because these strains are resistant to
most of the commonly used antibiotics [6]. In Europe, Sal-
monella caused more than 130,000 reported infections in
2008 and 108,614 cases in 2009. In the US more than a
million cases are estimated to occur [5,8].
Improved detection o f livestock colonised with S.
Typhimurium would be very helpful to prevent foodborne
diseases. In particular, infections in swine are difficult to
diagnose, because the animals develop either no or only
slight symptoms [9]. Only through continuous monitoring
of the herds infections of humans can be prevented. Estab-
lished methods for S. Typhimurium diagnostics are clas-
sically time-consuming, using microbiological cultures ontd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cence labeled DNA probes [12], PCR [13] or recently, a
quantum dot-based bead assay [14]. Currently, high
throughput diagnostic of S. Typhimurium is performed by
indirect ELISA [9,15,16]. The commercially available
ELISA kits e. g. SALMOTYPEW- or EnterisolW-ELISA use
a mixture of O-antigens of Salmonella enterica subspecies
entirca serovars. They are based on the system established
by Nielson et al. [15]. Because of this mixture, cross-
reactions occur with other bacteria [15]. In addition, the
sensitivity varies between the different ELISA assays [17].
For a sensitive and specific ELISA, immunogenic and spe-
cies specific proteins are required [18]. The improvement
of detection methods, as well as the development of new
vaccines would be facilitated by the identification, charac-
terisation and validation of previously unknown immuno-
genic proteins.
The most common method for the identification of
immunogenic proteins is 2D-PAGE of cultured bacterial
pathogens and immunoblot using sera from infected
patients or animals followed by mass spectrometry or
microsequencing [19-24]. However, this method is lim-
ited. Differentially expressed proteins, e.g. dependent on
pathogen-host interaction, can not be detected. Further-
more, weakly expressed antigens may also not be identi-
fied. In these cases, antigen phage display may circumvent
these limitations. Our approach for the identification of
immunogenic proteins is phage display. Phage display
technology was invented by George P. Smith [25]. This
methods can be used both for the selection of antibodies
[26-29] and for the identification of immunogenic proteins
from genomic or cDNA libraries [30-34]. Here, the clon-
ing of randomly fragmented genomic DNA or cDNA into
phage display vectors should allow, in theory, the display
of all polypeptides encoded by the genome of the donor
or all polypeptides encoded by the transcriptome of the
donor, respectively [35,36]. In this study, we combined the
identification of immunogenic proteins by M13 phage dis-
play using genomic libraries from S. Typhimurium with
the selection of open reading frames without any subclon-
ing steps (Figure 1 left part) in order to improve the li-
brary quality [37,38].
Afterwards, the genes corresponding to the identified
immunogenic oligopeptides were cloned and produced
in E. coli (Figure 1 middle part). Using our phage display
based pipeline for the generation of human antibodies
[39], we were able to generate human, recombinant anti-
bodies against these antigens (Figure 1 right part).
Results
Generation of the Salmonella Typhimurium genomic
phage display library
Sonication of Salmonella DNA did not lead to clonable
DNA fragments, whereas the sonication of E. coli DNAas a control could be cloned without problems (data not
shown). Therefore, genomic DNA was digested with a
mixture of the 4 base pair cutters DpnI and AluI and the
6 base pair cutter AfeI to construct the Salmonella
Typhimurium genome library (Figure 2A). The digested
DNA was cloned into pHORF3 [38] resulting in a library
with 1.6x106 independent clones. The insert rate and
size was analysed by colony PCR (Figure 2B), which
indicated that more than 90% of the clones contain an
insert. The shortest inserts had a size of about 40 bp
while the longest inserts had a lenght of 2500–3000 bp
with an average length of about 500–800 bp. For the se-
lection of open reading frames, the library was packaged
with Hyperphage [37,40,41]. The packaged library was
also analysed by colony PCR (Figure 2C) resulting in
shorter DNA fragments compared to the initial library.
Selection of immunogenic Salmonella Typhimurium
oligopeptides
Pooled convalescent serum from pigs infected with Sal-
monella Typhimurium was used for the panning proced-
ure. In total, two panning rounds were performed and
184 oligopeptide phage clones were analysed by ELISA
for binding to serum IgGs. 58 oligopeptide phage clones
with different gene fragments were found to bind to the
porcine convalescent serum IgGs but not to the control
serum IgGs. For 19 gene fragments, no homologous
NCBI database hit was found. 31 of the identified pro-
teins showed a higher similarity to other Salmonella
entericia serovars (Table 1). One of the selected gene
fragments showed the best NCBI database hit to Sal-
monella Typhimurium, but the gene fragment was not
in frame (Table 2). Seven oligopeptide phage clones with
a good signal to noise ratio (three- to four-fold over
background) in the ELISA and the highest homology to
genes from Salmonella enterica spp. enterica serovar
Typhimurium were selected for further characterisation
(Table 3). Binding of the oligopeptide phage to convales-
cent serum IgGs, including the non-SalmonellaTyphimur-
ium hits and the out of frame Salmonella Typhimurium
hit, was verified in an additional ELISA with piglet serum
as negative control (data not shown).
Cloning of the complete ORFs of the identified
oligopeptides and antigen production
The correspoding complete protein coding sequence of
the identifed gene fragments was amplified from genomic
DNA (Figure 3A) and cloned into pET21A+. When the
ORF contained a leader peptide, it was replaced by the
pelB leader peptide by cloning into pET21A+pelB. It was
not possible to amplify the putative carbohydrate kinase
encoding gene from the genomic DNA. The antigens were
produced in 500 mL scale shake flasks, purified by IMAC
and verified by SDS-PAGE (Figure 3B). Five of six antigens
Figure 1 Schematic overview of the experimental pipeline allowing the selection and identification of immunogenic proteins, cloning
and production of the immunogenic proteins and the generation of recombinant antibodies against these antigens.
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cessfully. It was not possible to produce the hypothetical
protein STM14.Analysis of the identified immunogenic proteins with
different pig sera
The five full size antigens were tested with sera from ten
Salmonella Typhimurium positive classified pigs, using
the commercial SALMOTYPE Pig Screen ELISA, and
sera from four negative classified pigs. In addition, they
were tested with the pooled immune positive sera used
for the selection procedure and with a piglet serum as
negative control (Figure 4).
9 out of 10 positive sera bound better to the antigen
putative dihydroxyacid dehydratase compared to the
negative sera. This means, that 9 of the 10 positive sera
had a higher ELISA O.D. value compared to the negative
serum with the highest ELISA O.D. value.
7 out of 10 positive sera bound better to the antigen
putative electron transfer protein alpha compared to the
negative sera. The pooled immune sera (positive control)
contained either more or better binders against theantigens than any of the individual positive classified
samples.
7 out of 10 positive sera bound better to the antigen 2,4-
dieonyl-CoA-reductase compared to the negative sera.
Here, the piglet serum revealed a high antigen binding
capacity compared to the mixture of positive sera.
8 out of 10 as positive classifed sera bound better to
the antigen phage tail-like protein compared to the
negative classified sera.
8 out of 10 as positive classified sera bound better to
the antigen putative dimethyl sulphoxide reductase com-
pared to the negative classified sera.
Not all individual positive sera bound significantly bet-
ter than all four individual negative sera. However, in
general the positive sera showed better binding to all
identified immunogenic proteins compared to the nega-
tive sera.Generation of recombinant human antibodies against the
identified immunogenic proteins
Antibody fragments against all five antigens were
selected using the human naive antibody gene library
AB
C
Figure 2 A agarose gel of the digested genomic DNA of Salmonella Typhimurium. B agarose gel of a colony PCR of the cloned genomic
fragments. C agarose gel of a colony PCR of the inserts of Hyperphage packed phagemids.
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antigen ELISA using soluble scFv fragments (data not
shown). These binders were sequenced to identify
unique binders and analysed using VBASE2 (www.
vbase2.org) [42]. Human antibodies were successfully
generated against all five antigens.
The best binders were recloned into the pOPE101-XP
vector [43], produced in 1.6 L scale in the LEX system
and IMAC purified (Table 4). The yields were between
0.5 mg/L and 12 mg/L. Afterwards, the purified scFv
were analysed by titration ELISA (Figure 5). The EC50values of the scFv (monovalent) are given in Table 4. For
four scFv it was not possible to determine the EC50,
since the maximal binding was not reached in the titra-
tions ELISA.
Analysis scFv binding to Salmonella proteins by
immunoblot
Binding to linear epitopes was analysed by SDS-PAGE of
the antigens, followed by a Western Blot and an immu-
nostain using the purified scFv. All binders to putative
dihydroxyacid dehydratase, phage tail-like protein and
Table 1 Selected immunogenic Salmonella enterica proteins (without Salmonella serovar Typhimurium), including in












ATP-dependent Clp protease ATP-binding subunit yes 232 ZP_04657262 Tennessee
outer membrane ferrichrome receptor protein precursor yes 58 YP_002635837 Paratyphi C
Rhs-family protein yes 100 ZP_04657793 Tennessee
hypothetical protein SentesTyphi_03066 yes 294 ZP_03357516 Typhi
crotonobetaine/carnitine-CoA ligase no 135 YP_002635709 Paratyphi C
transposase B no 144 ZP_03224077 Kentucky
DNA polymerase I no 348 ZP_03381877. Typhi
nitrate reductase 2, gamma subunit no 89 ZP_03366843 Typhi
putative phage terminase, large subunit no 648 YP_002216031 Dublin
putative electron transfer flavoprotein alpha subunit yes 58 YP_002636467 Paratyphi C
hypothetical protein no 414 ZP_06535866 Typhi
Salmonellaentericaenterica_12643
exonuclease V subunit gamma no 86 ZP_04653610 Tennessee
bacteriophage Mu tail sheath protein no 182 ZP_02663881 Schwarzen-grund
pts system, glucose-specific iibc component no 109 ZP_02670079 Heidelberg
flagellar basal body P-ring protein no 60 ZP_03371027 Typhi
hth-type tranScriptional regulator no 710 ZP_02698922 Newport
DNA mismatch repair protein yes 122 YP_002638485 Paratyphi C
colanic acid biosynthesis protein WcaK no 270 ZP_02830210 Weltevreden
outer membrane fimbrial usher protein yes 171 ZP_03336471 Typhi
uroporphyrinogen-III synthase yes 49 ZP_03385917 Gallinarium
ATP-dependent metalloprotease yes 130 ZP_03385917 Typhi
aminoglycoside/multidrug efflux system yes 67 ZP_04657455. Tennessee
penicillin-binding protein no 56 ACN47454 Paratyphi C
C32 tRNA thiolase yes 123 ZP_03365647 Typhi
hypothetical protein SG0660 no 324 YP_002225743. Gallinarium
putative LysR-family transcriptional regulator no 48 AET55395 Gallinarium
23 S rRNA methyluridine methyltransferase yes 214 ZP_03356931 Typhi
hypothetical protein SeHA_C2934 yes 55 YP_002046718 Heidelberg
putative transport protein yes 55 ACN44236. Paratyphi C
hypothetical protein SPC_0823 yes 61 ZP_03365355 Typhi
nitrate reductase, alpha subunit yes 298 ZP_03217505 Virchow
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topes. Three of the four binders to putative electron
transfer protein alpha and the binder against 2,4-Table 2 Selected immunogenic Salmonella Typhimurium








maltose ABC transporter periplasmic
protein
260 NP_463094dienoyl-CoA-reductase did not bind in the immunoblot
(Table 4).
Discussion
Antibody phage display for generation of recombinant
antibody fragments [39,44-47] and the identification of
immunogenic proteins by phage display [30-32,38,48,49]
are established methods. But in this work, for the first
time a complete phage display based pipeline from anti-
gen identification to the generation of the corresponding
antibody fragments was shown. Oligopeptide phage


































Figure 3 A agarose gel of seven PCR amplified identified genes. M: m
transfer protein alpha; 3: 2,4-dienyl-CoA reductase, 4: phage tail like protein
STM14. B SDS-PAGE (12%) of five μL elution fraction of six IMAC purified im
2: putative electron transfer protein alpha; 3: 2,4-dienyl-CoA reductase, 4: p
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munogenic proteins compared to 2D-PAGE followed by
mass spectrometry or microsequencing [32,38,48,50].
The identification of immunogenic proteins via oligo-
peptide phage display is independent of the natural ex-
pression rate of the immunogenic protein, which also
allows the identification of low abundant proteins or
proteins only produced in host-pathogen interactions.
A disadvantage could be that only oligopeptides can
be selected which can be secreted by the SEC pathway
[38]. Interestingly, when using sonicated S. Typhimur-
ium DNA, the transformation rates were in the range
of 102 - 104 clones per transformation. This is very
low compared to the transformation rates of 105 for
sonicated genomic DNA of Mycoplasma hyopneumo-
niae or 106 clones for E. coli [38]. Hence, the sonic-
ation method appeared to be not applicable for some
bacteria species or strains when constructing genomic
libraries.arker; 1: putative. dihydroyacid dehydratase; 2: putative electron
; 5: putative dimethyl sulphoxide reductase; 6: hypothecial protein
munogenic proteins. M: marker; 1: putative dihydroyacid dehydratase;




Figure 4 ELISA for analysis of identified immunogenic Salmonella Typhimurium proteins with defined pig sera. 1: putative dihydroyacid
dehydratase; 2: putative electron transfer protein alpha; 3: 2,4-dienyl-CoA reductase, 4: phage tail like protein; 5: putative dimethyl sulphoxide
reductase. The sera from Salmonella-positive pigs (according to „Pig Screen“ ELISA) are marked dark blue, the sera from Salmonella-negative pigs
(according to „Pig Screen“ ELISA) are marked orange, the mixture of positive sera used for the selection of immunogenic proteins is marked
green, the piglet serum is marked dark red and the detection system control (only detection antibodies) is marked in light blue. For the panel of
positive and negative sera arithmetic mean and standard deviation are given as black lines. 1 μg purified antigens were coated. The antigens
were detected with diluted swine sera (1:200 in 2% MPBST) and goat anti-swine IgG HRP conjugate (1:10,000).
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Table 4 Characterisation of antibody fragments generated against Salmonella Typhimurium antigens. n.d. = EC50 not
determined
scFv Target VH VL Yield [mg/L] EC50 [nM] EC 50 [μg/mL] Immuno-blot
TM228.2.3-B1 putative dihydroxyacid dehydratase IGHV3-48*03 IGLV3-19*01 3.8 40 1.2 yes
TM228.2.3-D9 putative dihydroxyacid dehydratase IGHV3-23*01 IGLV1-50*01 8.4 160 4.6 yes
TM228.2.3-H7 putative dihydroxyacid dehydratase IGHV1-18*01 IGLV3-19*01 12.0 310 9.4 yes
TM228.3.3-A5 putative electron transfer protein alpha IGHV1-46*01 IGLV7 4.3 78 2.3 yes
TM228.3.3-C5 putative electron transfer protein alpha - IGLV3-21*02 7.9 n.d. n.d. no
TM228.3.3-D3 putative electron transfer protein alpha IGHV5-51*01 IGLV3-1*01 7.6 n.d. n.d. no
TM228.3.3-F10 putative electron transfer protein alpha IGHV1-46*01 IGLV3-19*01 0.5 n.d. n.d. no
TM228.4.3-A4 2,4-dienoyl-CoA-reductase IGHV3-15*01 IGLV3-19*01 1.3 310 9.4 no
TM228.5.3-G7 phage tail-like protein IGHV1-2*02 IGLV1-47*01 7.4 310 9.4 yes
TM228.6.3-A12 putative dimethyl sulphoxide reductase IGHV1-69*01 IGLV3-19*01 1.1 n.d. n.d. yes
TM228.6.3-C5 putative dimethyl sulphoxide reductase IGHV4-31*03 IGLV1-44*01 1.5 625 18.8 yes
TM228.6.3-H2 putative dimethyl sulphoxide reductase IGHV4-59*01 IGLV1-44*01 2.8 625 18.8 yes
The V genes are given according to VBASE2 (www.vbase2.org).
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convalescent serum from pigs infected with Salmonella
Typhimurium. Interestingly, many of the encoding gene
fragments were not in frame with gIII and therefore, in
theory, should not result in the production of functional
oligopeptide-pIII fusion proteins. However, similar
observations, that gene fragments encoding oligo- or
polypeptides frequently contain frameshifts, have been
described previously for selections by phage display
[37,51]. For +1 frameshifts it is reported that oligo- or
polypeptides are still displayed on phage particles with
the same amino acid sequence as the corresponding
constructs without a frameshift. One suggested explan-
ation of this effect was the occurrence of RNA second-
ary structures. A second explanation could be the
selection pressure against oligo- or polypeptides which
are toxic for E. coli and thus may lead to a negative se-
lection against these potential toxic proteins [52].
The most frequently identified oligopeptides did not
show the best match with the Salmonella serovar Typhi-
murium (NCBI taxonomy IDs: 99287, 588858 and
568708), but instead with other Salmonella serovars.
These antigens with a higher homology to other Salmon-
ella serovars, could be interesting for further analyses.
However in this work, we focused on the seven antigens
with the highest homology to Salmonella Tyhphimur-
ium. In contrast to former selections of immunogenic
proteins using the pHORF system, where both new and
known immunogenic proteins were selected [32,38],
these seven antigens have not been described as im-
munogenic before. So far, five immunogenic proteins of
S. Typhimurium were found using 2D-PAGE [53]. Puta-
tive dihydroxyacid dehydratase, putative dimethyl
sulphoxide reductase and hypothetical protein STM14 ofSalmonella Typhimurium have not been described as
immunogenic before. The putative electron transfer pro-
tein alpha [54] is located on a pathogenicity island [55].
To date, 2,4-dienoyl-CoA-reductase of S. Typhimurium
has not been identified as immunogenic, but interest-
ingly, humans exhibiting anti-mitochondrial autoanti-
bodies (AMA-positive), have also antibodies against the
human 2,4-dienoyl-CoA-reductase [56]. For the phage
tail-like protein, a bactericidal activity is described for
some bacteria, e.g. Pseudomonas [57]. Immunogenic
proteins from S. Typhimurium, which are used for diag-
nostics, are only rarely described in the literature.
Described are OmpD [58] and a preparation of flagelates
[59] for ELISA diagnostics. For nanobead based assays
polyclonal antibodies against Salmonella were used
whereupon the detailed antigens are unknown [14]. The
V genes of the selected scFv against the five immuno-
genic proteins are mainly derived from the HV families
1 and 3 and from the LV families 1 and 3. Member of
these gene families are preferentially selected from naive
scFv libraries [60,61]. Only scFv with a lambda VL but
no kappa VL were selected. Interestingly, also one VL
domain only binder was selected. This is an artefact
from library cloning since the insert rate of HAL7 is not
100% [39]. Functional VL domain dAbs have been
described before [62].
The gold standard for diagnostics of Salmonella
infections is microbiological culture [18]. Currently,
for high throughput detection of S. Typhimurium,
ELISA is the ideal method [9,15,16,58]. The commer-
cially available ELISA kits use a mixture of O-antigens
(LPS) or total cell lysate of Salmonella enterica sub-
species entirca serovars. This mixture of antigens




Figure 5 Titration ELISA to analyse the selected anti-Salmonella Typhimurium antigens scFv. 1: putative dihydroyacid dehydratase; 2:
putative electron transfer protein alpha; 3: 2,4-dienyl-CoA reductase, 4: phage tail like protein; 5: putative dimethyl sulphoxide reductase. 1 μg
purified antigens were coated and detected with a dilution series of purifed scFv. Bound scFv fragments were detected with the anti myc 1-9E10
(1:500) and the goat-α-mouse-IgG (Fab spec.) HRP-conjugate (1:10,000).
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showed “both sample matrices, blood sera and meat
juice, are suitable for antibody detection. However, the
test sensitivity mainly depends on the respective cut-
off used for the specific test” and “our findings indi-
cate that the currently used LPS-ELISA systems havediagnostic uncertainties. . .” [9]. The use of one or a
defined mixture of the selected immunogenic proteins
and the corresponding antibody fragments will be use-
ful to establish an ELISA based diagnostic kit with a
higher specificity compared to the commercially avail-
able diagnostic kits.
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Construction of the Salmonella Typhimurium genomic
phage display library
Salmonella Typhimurium was cultivated in 2xTY
medium [63] overnight at 34°C and 250 rpm. For isola-
tion of genomic DNA, 6x 3 ml of the culture were used.
The isolation was performed with the Quiaamp DNA
Mini Kit according to the manufacturer’s instructions
(Qiagen, Hilden, Germany). After purification, the DNA
was digested for 35 min using three different blunt end-
cutting restriction endonucleases (AluI, AfeI, DpnI)
(NEB, Frankfurt, Germany). DNA fragments with a size
up to 1200 bp, were used for cloning into the PmeI-
restricted vector pHORF3 [38]. The ligated plasmids
were transformed into E. coli Top10 F´ (Invitrogen,
Karlsruhe, Germany) by electroporation.
Enrichment of ORFs using Hyperphage
The enrichment of ORFs in the S. Typhimurium gen-
omic library requires the display of the corresponding
polypeptides on phage particles for the panning. There-
fore, the library was packaged using Hyperphage [40,41]
as described previously [37,38].
Colony PCR
E. coli clones bearing pHORF3 were analysed by colony
PCR using the primers MHLacZPro_f (5' GGCTCGTATG
TTGTGTGG 3'), MHgIII_r (5' GGAAAGACGACAAAA
CTTTAG 3'), and the following protocol: 94°C 1 min, 56°C
0.5 min, 72°C 1.5 min, 25 cycles. The DNA was separated
by 1% Agarose gel electrophoresis.
Selection of immunogenic oligopeptides (Panning)
The panning was performed by following the protocol
described before [38] with modifications. Six wells of a
MaxiSorpW 96-well microtitre plate (MTP; Nunc, Wies-
baden, Germany) were coated with 150 μL 5 μg/mL goat
anti-swine IgG in PBS [63] overnight. The wells were
washed with phosphate buffered saline (PBS) supple-
mented with 0.1% Tween20 (PBST) (Roth, Karlsruhe,
Germany). Afterwards, they were blocked with PBST
supplemented with 2% (w/v) skim milk powder (2%
MPBST) for 1 h. In parallel, several wells of a Maxi-
SorpW plate were coated with 150 μL 1× 1011 cfu/mL
Hyperphage in PBS overnight and blocked with 2%
MPBST for 1 h. All washing steps were performed three
times using PBST buffer and an enzyme-linked immuno-
sorbent assay (ELISA) washer (Tecan Columbus, Crail-
sheim, Germany). A swine serum mixture (obtained
from pigs after infection with S. Typhimurium and field
sera) was diluted 1:10 in 2% MPBST and pre-incubated
on MaxiSorpW MTP wells coated with Hyperphage for
1 h at RT, to remove serum IgG binding to the helper-
phage. After pre-incubation, the swine serum wasincubated in goat anti-swine IgG-coated MTP wells for
2 h. After washing, 5 × 1010 cfu polypeptide phage parti-
cles of the Hyperphage-packaged Salmonella Typhimur-
ium genomic library were incubated on the captured
swine IgGs for 2 h. For the following panning rounds,
100 μL of amplified phage of the previous panning round
were used. The non-binding polypeptide phage particles
were removed by ten stringent washing steps. In the sec-
ond and third panning round, the number of washing
steps was increased to 20 and 30, respectively. Elution of
bound phage particles was performed using 200 μL of
10 μg/ml trypsin (10 μg/mL trypsin in PBS) for 30 min at
37°C. Ten microlitres of the eluted phage solution were
used for titration. Twenty millilitres of the E. coli TOP10
F´ cells were grown to an OD600 of 0.4 - 0.5 which were
then infected with the remaining 190 μL of the eluted
phage solution and incubated for 30 min at 37°C. After-
wards, the cells were harvested by centrifugation for
10 min at 3.220 × g. The bacterial pellet was resuspended
in 250 μL 2 ×TY medium (1.6% [w/v] tryptone, 1% [w/v]
yeast, 0.5%[w/v] NaCl) containing 100 mM glucose and
100 μg/mL ampicillin (2 ×TY-GA), plated onto 15 cm
2×TY-GA agar plates and incubated overnight at 37°C.
Grown colonies were harvested in 5 mL 2 ×TY-GA
medium using a Drigalsky spatula. Fifty millilitres of
2 ×TY-GA medium were inoculated with 200 μL bacteria
culture and grown to an OD600 of 0.4-0.5 at 37°C and
250 rpm in a shaking incubator. Five millilitres of bacter-
ial culture corresponding to about ~2.5 × 109 cells were
infected with 5 × 1010 cfu Hyperphage, incubated at 37°C
for 30 min without shaking and another 30 min with
shaking at 250 rpm. The infected cells were harvested by
centrifugation for 10 min at 3.220xg. The pellet was
resuspended in 30 mL 2xTY medium containing 100 μg/
mL ampicillin and 50 μg/mL kanamycin (2 ×TY-AK).
Phage particles were produced at 30°C and 250 rpm
overnight. On the following day, the supernatant con-
taining phage particles was collected.
Production of individual oligopeptide phage clones for
screening
For phage production, polypropylene 96-well U bottom
plates (Greiner bio-one, Frickenhausen, Germany) con-
taining 175 μL 2xTY-GA per well were inoculated with
single E. coli colonies from the phage titration plates of
the third panning round and incubated at 37°C with
constant shaking at 850 rpm (thermo shaker PST60-
HL4, lab4you, Berlin, Germany) overnight. A new plate
with 165 μL 2xTY-GA per well was inoculated with 10
μL of the overnight cultures and incubated at 37°C and
850 rpm for 2 h. Afterwards, the bacteria were infected
with 5x109 cfu Hyperphage/well and incubated at 37°C
without shaking for 30 min, followed by shaking at
850 rpm for 30 min. The MTP plate was centrifuged at
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Afterwards, the bacterial pellets were resuspended in
175 μL/well 2xTY containing 100 mg/mL ampicillin and
30 μg/mL kanamycin (2xTY-AK) and incubated at 30°C
at 850 rpm overnight for phage production. The bacteria
were pelleted again and the supernatants were trans-
ferred to a new plate. The phage were precipitated with
1/5 volume 20% PEG/2.5 M NaCl solution at 4°C for 1 h
and centrifuged at 3,220xg for 1 h. The phage pellet was
dissolved in 150 μL PBS and residual bacteria were
removed by another centrifugation at 3,220xg for 5 min.
The phage containing supernatants were stored at 4°C
or directly used for ELISA.
Screening of individual oligopeptide phage clones
For phage ELISA, the produced polypeptide phage parti-
cles were captured. Here, 100 μL of 250 ng/mL mouse
anti-M13 (B62-FE2, Progen, Freiburg, Germany) in PBS
were coated at 4°C overnight. After coating the wells
were blocked with 2% MPBST. Between each incubation
step the wells were washed three-times with PBST using
an ELISA washer. 150 μL of the monoclonal phage pro-
duction were incubated for 2 h. The pig convalescent
serum was diluted 1:200 in 2% MPBST supplemented
with 1/10 volume E. coli cell lysate and 1x1010 cfu
Hyperphage/mL, added to the captured phage particles
and incubated for 2 h. The bound pig IgGs were
detected with goat anti-swine IgG conjugated with
horseradish peroxidase (HRP) (1:1000) for 1.5 h and
visualised with TMB (3,3´,5,5´-tetramethylbenzidine)
substrate. The staining reaction was stopped by adding
100 μL 1 N sulphuric acid. The absorbances at 450 nm
and scattered light at 620 nm were measured and the
620 nm value was subtracted using a SUNRISE microti-
ter plate reader (Tecan, Crailsheim, Germany).
Cloning of the fullsize gene fragments
The corresponding proteins of the identified immuno-
genic polypeptides were amplified by PCR using the gen-
omic DNA and the following oligonucleotide primers:
TM208-forward (5´ AAGGAGATATACATATGAGC
CAAAAATGTCAACATGCT 3´), TM208-reverse (5´
CTCGAGTGCGGCCGCTTTAAGCCAGGCTCCGGCC
ATTAA 3`) for putative dihydroxyaciddehydratase,
TM209-forward (5´ AAGGAGATATACATATGGCTTC
TTTAGTTATTGCTGAACAT 3´), TM209-reverse (5´
CTCGAGTGCGGCCGCTAATTTATCGATAAGTTCA
GGTAC 3´) for putative electron transfer protein alpha,
TM210-forward (5´ AAGGAGATATACATATGAGCTA
CCCGTCGCTGTTCGCCCCG 3´), TM210-reverse (5´
CTCGAGTGCGGCCGCAATCTCCAGTGCCAGTCGG
GTGCC 3´) for 2,4-dieonyl-CoAreductase, TM211-
forward (5´ AAGGAGATATACATATGAATAGTCTGT
TGCCGCCGGGTTCG3´), TM211-reverse (5´ CTCGAGTGCGGCCGCTGGATTCACTCTCATTGTGTCAAT
3´) for phage tail-like protein, TM212-forward (5´ CAG
CCGGCCATGGCTTCAATGAATAAAGCAGTCAGTA
GTGAG 3´), TM212-reverse (5´ CTCGAGTGCGGCCG
CACGTGCCGGGCGGTATTCGCGCCA 3´) for puta-
tive carbohydratekinase, TM213-forward (5´ CAGCCGG
CCATGGCTGCGGTGCAGCAGGCTATGCGCAACG
AA 3´), TM213-reverse (5´ TGCGGCCGCAAGCTT
GATTTTTTCGATTTCCACCAGATTTGT 3´) for pu-
tative dimethyl sulphoxide reductase chain A1, and
TM214-forward (5´ AAGGAGATATACATATGATGTC
AGCATGTTTTTTTGGCCGA 3´), TM214-reverse (5´
CTCGAGTGCGGCCGCATCAATTATTTTGGTGAGT
GTTTG 3´) for hypothetical protein STM14. The PCR
was performed using the following protocol: 98°C 30 sec,
98°C 10 sec, 60°C 20 sec, 72°C 120 sec, 24 cycles. The DNA
was separated by electrophoresis in a 1% agarose gel. The
bands of interest were cut out from the gel, the DNA was
eluted and used for cloning into pET21A+or pET21A+
pelB. After ligation the plasmids were transformed into E.
coli BLR-DE3. Positive clones were identified by using col-
ony PCR using the oligonucleotide primers MHpET21_f1
(5´ GAGCGGATAAC AATTCCCC 3´) and MHpET21_r1
(5´ GCAGCCAACT CAGCTTCC 3´).
Production of the immunogenic proteins
Five hundred mL 2xTY-GA medium were inoculated
with 5 mL overnight culture and cultivated to an O.D.600
of 1.0 at 37°C and 250 rpm. The expression was induced
with 1 mM IPTG (final concentration) overnight. Cells
were harvested by centrifugation at 7.500 xg for 15 min.
Lysis was performed with 1 mg/mL lysozyme and 5 μg/
mL DNAseI in 15 mL His-tag binding buffer pH7.4
(20 mM Na2HPO4, 0.5 M NaCl, 10 mM Imidazol). For
Isolation of inclusion bodies 8 M Urea was added. The
purification was performed under denaturing conditions
with FastFlow Sepharose (GE Healthcare) loaded with
nickel. The Sepharose was washed with 10 mM, 30 mM
and 60 mM imidazole (20 mM Na2HPO4, 0.5 M NaCl,
10, 30 or 60 mM Imidazol). For elution, 5 mL 100 mM
EDTA in PBS supplemented with 8 M urea were used.
SDS-PAGE
Antigens were analysed by 12% SDS-PAGE using a Pro-
tean II Minigel system (BioRad Inc, München, Germany)
according to [63]. Protein gels were stained with coo-
massie blue.
Enzyme linked immunosorbent assay (ELISA) for
verification of immunogenic proteins
One μg of antigen was coated to 96 well microtitre
plates (MaxiSorp, Nunc) in 50 mM NaHCO3 pH 9.6
overnight at 4°C. After coating, the wells were washed
three times with PBST and blocked with 2% MPBST for
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For serum ELISA, sera were diluted 1:200 in 100 μL
2%MPBST and incubated in the antigen coated plates
for 1.5 h at RT, followed by three PBST washing cycles.
Bound pig IgGs were detected with goat anti-swine IgG
HRP conjugate (1:10,000) (Dianova, Hamburg, Ger-
many). The visualisation was performed with TMB
(3,3´,5,5´-tetramethylbenzidine) as a substrate and the
staining reaction was stopped by adding 100 μl 1 N
sulphuric acid. Absorbance at 450 nm was measured by
using a SUNRISE™ microtitre plate reader (Tecan, Crail-
sheim, Germany).
Generation of antibodies against the identified antigens
The selection of recombinant antibodies was performed
according to [64] with modificiations. In short, pannings
were performed in 96 well microtitre plates (MaxiSorp,
Nunc, Wiesbaden, Germany). One μg of antigen was
coated in PBS pH 7.4 [63] overnight at 4°C. The
antigen-coated wells and wells for the preincubation of
the library were blocked with 2% MPBST. In each case
2.5x1011 phage particles of the human naive antibody
gene libraries HAL7 and HAL8 [39] were diluted in
PBST with 1% skim milk and 1% bovine serum albumin
(BSA) and preincubated for 1 h. The supernatant, con-
taining the depleted library, was incubated in the
antigen-coated wells at RT for 2 h followed by 10 wash-
ing steps with PBST. Afterwards, bound scFv phage par-
ticles were eluted with 200 μL trypsin solution (10 μg/
mL trypsin in PBS) at 37°C for 30 min. The supernatant
containing eluted scFv phage particles was transferred
into a new tube. Ten μL of eluted scFv phage were used
for titration as described before [64]. Twenty mL E. coli
XL1-Blue MRF' (Agilent, Böblingen, Germany) culture
in the logarithmic growth phase (O.D.600 = 0.4 - 0.5)
were infected with the remaining scFv-phage at 37°C for
30 min without shaking. The infected cells were har-
vested by centrifugation for 10 min at 3220xg and the
pellet was resuspended in 250 μL 2xTY medium [63]
supplemented with 100 mM glucose and 100 μg/mL
ampicillin (2xTY-GA), plated on a 15 cm 2xTY agar
plate supplemented with 100 mM glucose and 100 μg/
mL ampicillin and incubated overnight at 37°C. Grown
colonies were harvested with 5 mL 2xTY-GA. Thirty mL
of 2xTY-GA were inoculated with 100 μL of the har-
vested colony suspension and grown to an O.D.600 of 0.4
to 0.5 at 37°C and 250 rpm. Five mL bacteria suspension
(~2,5x109 bacteria) were infected with 5x1010 helperph-
age M13K07 (Stratagene), incubated at 37°C for 30 min
without shaking, followed by 30 min at 250 rpm.
Infected cells were harvested by centrifugation for
10 min at 3220 xg and the pellet was resuspended in
30 mL 2xTY supplemented with 100 μg/mL ampicillin
and 50 μg/mL kanamycin (2xTY-AK). Antibody phagewere produced at 30°C and 250 rpm for 16 h. Cells were
harvested by centrifugation for 10 min at 3220xg. The
supernatant containing the antibody phage (~1x1012 cfu/
mL) were directly used for the next panning round or
stored at 4°C for a few days.
Production of scFv in microtitre plates (MTPs)
The identification of monoclonal binders was performed
as described before [43]. In brief, 96-well MTPs with
polypropylene (PP) wells (U96 PP 0.5 mL, Greiner,
Frickenhausen, Germany) containing 150 μL phosphate
buffered 2xTY-GA [63] (2xTY-GA supplemented with
10% (v/v) potassium phosphate buffer (0.17 M KH2PO4,
0.72 M K2HPO4)) were inoculated with colonies from
the titration plate of the third panning round. MTPs
were incubated overnight at 37°C at 1000 rpm in a MTP
shaker (Thermoshaker PST-60HL-4, Lab4You, Berlin,
Germany). A volume of 180 μL phosphate-buffered
2xTY-GA in PP-MTP well was inoculated with 10 μL of
the overnight culture and grown at 37°C and 800 rpm
for 2 h. Bacteria were harvested by centrifugation for
10 min at 3220xg and 180 μL supernatant were
removed. The pellets were resuspended in 180 μL buf-
fered 2xTY supplemented with 100 μg/mL ampicillin,
100 mM sucrose an 50 μM isopropyl-beta D thiogalacto
pyranoside (IPTG) and incubated at 30°C and 800 rpm
overnight. Bacteria were pelleted by centrifugation for
10 min at 3,220 xg and 4°C. The scFv-containing super-
natant was transferred to a new PP-MTP and stored at
4°C before analysis.
Identification of monoclonal scFv using ELISA
Antigen coating was performed as described above (En-
zyme linked immunosorbent assay (ELISA) for verifica-
tion of immunogenic proteins). For identification of
binders, supernatants containing monoclonal scFv were
incubated in the antigen coated plates for 1.5 h at RT
followed by three PBST washing cycles. Bound scFv
were detected using murine mAb 9E10 which recognises
the C-terminal c-myc tag and a goat anti-mouse serum
conjugated with horseradish peroxidase (HRP) (Sigma;
1:10,000).
The detection was performed as described above.
Production of scFv in the LEX system
The large-scale expression system (LEX) (Harbinger
Biotech, Toronto, Canada) was used for production of
scFv. E. coli (XL1-Blue-MRF') was cultivated in 2 L glass
bottles up to a cultivation volume of 1.5 L. To obtain suffi-
cient oxygenation and mixing of the culture, the bottles
were connected to an air manifold, which allows a general
air flow rate of 4–6 L/min. A thermostat-controlled water
bath was used for regulating the temperature of the culti-
vation. 50 ml TB supplemented with 100 μg/mL
Meyer et al. BMC Biotechnology 2012, 12:29 Page 13 of 15
http://www.biomedcentral.com/1472-6750/12/29ampicillin were inoculated with a glycerol stock of each
scFv clone and the culture was grown over night at
37°C. Glass bottles with 1.5 L TB supplemented with
100 μg/mL ampicillin and 500 μL antifoam 204 (Sigma,
München, Germany) were inoculated with the overnight
culture. The O.D.600 was adjusted to 0.1 and incubated
at 37°C until an O.D.600 of 1.5 to 5 was reached. The
temperature of the water bath was then reduced to
25°C. After 1 h, scFv expression was induced by
addition of 50 μM IPTG. The cultivation was continued
for 3 h resulting in a final O.D.600 of 2 to 7 depending
on the antibody clone. E. coli cells were harvested by
centrifugation at 4,400xg (Sorvall Zentrifuge RC6 Plus,
Rotor F9S-4x1000Y) for 10 min at 4°C. The pellet was
resuspended in 60 mL ice-cold PE-buffer pH 8 (20% (w/
v) sucrose, 50 mM Tris, 1 mM EDTA) and was incu-
bated on ice for 20 min while shaking. Afterwards the
sample was centrifuged at 20,000xg and 4°C for 30 min
(Sorvall Zentrifuge RC6 Plus, Rotor F12-6x500y). The
supernatant (periplasmatic preparation) was filled into a
fresh glass bottle and kept on ice. The pellet was re-
suspended in 60 mL ice-cold OS-buffer (5 mM MgSO4
in dH2O) and was incubated on ice while shaking. After
20 min the preparation was centrifuged at 20,000xg and
4°C for 30 min (Sorvall Zentrifuge RC6 Plus, Rotor F12-
6x500y). The supernatant (osmotic shock fraction) was
combined with the periplasmatic preparation and was
used for protein purification.IMAC purification of scFv
Antibody fragments were purified by affinity chromatog-
raphy using IMAC. Chromatography using Profinia
(BioRad) and 1 mL FF-crude column (GE Healthcare,
München, Germany) was performed according to the
manufacturer's instruction. The protein solution was
adjusted to 10 mM imidazol containing buffer (20 mM
Na2HPO4, 500 mM NaCl, 10 mM imidazol) for loading.
The column was washed one time with 10 mM imidazol
buffer (20 mM Na2HPO4, 500 mM NaCl, 10 mM imida-
zol). Five hundred mM imidazol was used for elution,
followed by desalting and storage in PBS.Titration ELISA using scFv
For the scFv titration ELISA the antigen was coated as
described above (Enzyme linked immunosorbent assay
(ELISA) for verification of immunogenic proteins). The
ELISA was performed as described above (Identification
of monoclonal scFv using ELISA) with one modification:
a dilution series of IMAC purified scFv was used instead
of the scFv supernatant. The EC50 values (antibody con-
centration at the half maximal binding) are deduces
from this titration ELISA.Detection of the immunogenic proteins by immunostain
using scFv
Purified immunogenic proteins were separated by 12%
SDS-PAGE. Western Blotting on PVDF (Polyvinyliden-
fluorid) membranes of gels was performed using the Mini
Trans-BlotW system (BioRad). The membrane was blocked
with 2% (w/v) skimmed milk powder in PBST over night.
The antigens were detected with 20 μg/mL scFv for
1 h at RT. The scFv myc-tag was detected with mouse
anti myc-tag (9E10, Sigma, Taufkirchen, Germany) for
1 h, followed by goat anti-mouse (Fc specific) (Sigma)
conjugated with alkaline phosphatase (1:20,000) for 1 h.
The visualisation was performed by addition of BCIP (5-
bromo-4-chloro-3-indolyl phosphate) and NBT (nitro-
blue tetrazolium).
Conclusion
A “pipeline” from antigen identification to the gener-
ation of recombinant antibodies using phage diplay was
shown. Here, novel immunogenic proteins of Salmonella
Typhimurium were identified using phage display and
validated using a panel of positive and negative sera.
Afterwards, recombinant human antibody fragments
were generated against these marker proteins.
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